PD-1/L1 With or Without CTLA-4 Inhibitors Versus Chemotherapy in Advanced Non-Small Cell Lung Cancer

BACKGROUND: With the use of immune-checkpoint inhibitors (ICIs) in advanced or metastatic non-small cell lung cancer (NSCLC), whether ICIs or chemotherapy is more effective still remains controversial. This study was conducted to evaluate the efficacy of programmed cell death 1 (PD-1), programmed ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Luyong, Liang, Jiali, Dai, Wei, Li, Jiayu, Si, Yuexiu, Ren, Wei, Lu, Yan, Chen, Danqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185001/
https://www.ncbi.nlm.nih.gov/pubmed/35673884
http://dx.doi.org/10.1177/10732748221107590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185001/
https://www.ncbi.nlm.nih.gov/pubmed/35673884
http://dx.doi.org/10.1177/10732748221107590

Ejemplares similares